1330 related articles for article (PubMed ID: 32816830)
1. Does Fibre-fix provided to people with irritable bowel syndrome who are consuming a low FODMAP diet improve their gut health, gut microbiome, sleep and mental health? A double-blinded, randomised controlled trial.
Yan R; Murphy M; Genoni A; Marlow E; Dunican IC; Lo J; Andrew L; Devine A; Christophersen CT
BMJ Open Gastroenterol; 2020 Aug; 7(1):. PubMed ID: 32816830
[TBL] [Abstract][Full Text] [Related]
2. The gut microbiome as a predictor of low fermentable oligosaccharides disaccharides monosaccharides and polyols diet efficacy in functional bowel disorders.
Chumpitazi BP
Curr Opin Gastroenterol; 2020 Mar; 36(2):147-154. PubMed ID: 31850930
[TBL] [Abstract][Full Text] [Related]
3. Randomised clinical trial: low-FODMAP rye bread vs. regular rye bread to relieve the symptoms of irritable bowel syndrome.
Laatikainen R; Koskenpato J; Hongisto SM; Loponen J; Poussa T; Hillilä M; Korpela R
Aliment Pharmacol Ther; 2016 Sep; 44(5):460-70. PubMed ID: 27417338
[TBL] [Abstract][Full Text] [Related]
4. Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome.
Hustoft TN; Hausken T; Ystad SO; Valeur J; Brokstad K; Hatlebakk JG; Lied GA
Neurogastroenterol Motil; 2017 Apr; 29(4):. PubMed ID: 27747984
[TBL] [Abstract][Full Text] [Related]
5. A low FODMAP diet plus traditional dietary advice versus a low-carbohydrate diet versus pharmacological treatment in irritable bowel syndrome (CARIBS): a single-centre, single-blind, randomised controlled trial.
Nybacka S; Törnblom H; Josefsson A; Hreinsson JP; Böhn L; Frändemark Å; Weznaver C; Störsrud S; Simrén M
Lancet Gastroenterol Hepatol; 2024 Jun; 9(6):507-520. PubMed ID: 38643782
[TBL] [Abstract][Full Text] [Related]
6. Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial.
Cox SR; Lindsay JO; Fromentin S; Stagg AJ; McCarthy NE; Galleron N; Ibraim SB; Roume H; Levenez F; Pons N; Maziers N; Lomer MC; Ehrlich SD; Irving PM; Whelan K
Gastroenterology; 2020 Jan; 158(1):176-188.e7. PubMed ID: 31586453
[TBL] [Abstract][Full Text] [Related]
7. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome.
Chumpitazi BP; Cope JL; Hollister EB; Tsai CM; McMeans AR; Luna RA; Versalovic J; Shulman RJ
Aliment Pharmacol Ther; 2015 Aug; 42(4):418-27. PubMed ID: 26104013
[TBL] [Abstract][Full Text] [Related]
8. The long-term effect and adherence of a low fermentable oligosaccharides disaccharides monosaccharides and polyols (FODMAP) diet in patients with irritable bowel syndrome.
Weynants A; Goossens L; Genetello M; De Looze D; Van Winckel M
J Hum Nutr Diet; 2020 Apr; 33(2):159-169. PubMed ID: 31637777
[TBL] [Abstract][Full Text] [Related]
9. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.
Halmos EP; Power VA; Shepherd SJ; Gibson PR; Muir JG
Gastroenterology; 2014 Jan; 146(1):67-75.e5. PubMed ID: 24076059
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal tolerance of low FODMAP oral nutrition supplements in healthy human subjects: a randomized controlled trial.
Erickson J; Korczak R; Wang Q; Slavin J
Nutr J; 2017 May; 16(1):35. PubMed ID: 28545589
[TBL] [Abstract][Full Text] [Related]
11. Dietary Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAPs) and Gastrointestinal Disease.
Vakil N
Nutr Clin Pract; 2018 Aug; 33(4):468-475. PubMed ID: 29870082
[TBL] [Abstract][Full Text] [Related]
12. Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet.
Staudacher HM; Whelan K
Proc Nutr Soc; 2016 Aug; 75(3):306-18. PubMed ID: 26908093
[TBL] [Abstract][Full Text] [Related]
13. Nutritional, microbiological and psychosocial implications of the low FODMAP diet.
Staudacher HM
J Gastroenterol Hepatol; 2017 Mar; 32 Suppl 1():16-19. PubMed ID: 28244658
[TBL] [Abstract][Full Text] [Related]
14. Fecal Fermentation in Irritable Bowel Syndrome: Influence of Dietary Restriction of Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols.
Valeur J; Røseth AG; Knudsen T; Malmstrøm GH; Fiennes JT; Midtvedt T; Berstad A
Digestion; 2016; 94(1):50-6. PubMed ID: 27487397
[TBL] [Abstract][Full Text] [Related]
15. Low fermentable, oligo-, di-, mono-saccharides and polyol diet in the treatment of irritable bowel syndrome: A systematic review and meta-analysis.
Schumann D; Klose P; Lauche R; Dobos G; Langhorst J; Cramer H
Nutrition; 2018 Jan; 45():24-31. PubMed ID: 29129233
[TBL] [Abstract][Full Text] [Related]
16. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial.
Böhn L; Störsrud S; Liljebo T; Collin L; Lindfors P; Törnblom H; Simrén M
Gastroenterology; 2015 Nov; 149(6):1399-1407.e2. PubMed ID: 26255043
[TBL] [Abstract][Full Text] [Related]
17. Exploring Gut Microbiota Composition as an Indicator of Clinical Response to Dietary FODMAP Restriction in Patients with Irritable Bowel Syndrome.
Valeur J; Småstuen MC; Knudsen T; Lied GA; Røseth AG
Dig Dis Sci; 2018 Feb; 63(2):429-436. PubMed ID: 29302878
[TBL] [Abstract][Full Text] [Related]
18. Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet compared with traditional dietary advice for diarrhea-predominant irritable bowel syndrome: a parallel-group, randomized controlled trial with analysis of clinical and microbiological factors associated with patient outcomes.
Zhang Y; Feng L; Wang X; Fox M; Luo L; Du L; Chen B; Chen X; He H; Zhu S; Hu Z; Chen S; Long Y; Zhu Y; Xu L; Deng Y; Misselwitz B; Lang BM; Yilmaz B; Kim JJ; Owyang C; Dai N
Am J Clin Nutr; 2021 Jun; 113(6):1531-1545. PubMed ID: 33740048
[TBL] [Abstract][Full Text] [Related]
19. Low fermentable oligo-di-mono-saccharides and polyols diet versus general dietary advice in patients with diarrhea-predominant irritable bowel syndrome: A randomized controlled trial.
Zahedi MJ; Behrouz V; Azimi M
J Gastroenterol Hepatol; 2018 Jun; 33(6):1192-1199. PubMed ID: 29159993
[TBL] [Abstract][Full Text] [Related]
20. Intestinal microbiota fingerprint in subjects with irritable bowel syndrome responders to a low FODMAP diet.
Valdez-Palomares F; Nambo-Venegas R; Uribe-García J; Mendoza-Vargas A; Granados-Portillo O; Meraz-Cruz N; Palacios-González B
Food Funct; 2021 Apr; 12(7):3206-3218. PubMed ID: 33877245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
